Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada

References

• Mattson CL, Tanz LJ, Quinn K, et al. Trends and geographic patterns in drug and synthetic opioid overdose Deaths – United States, 2013-2019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202–207.
   PubMed Web of Science ®Google Scholar
• CDC. Drug Overdose Deaths in the U.S. Top 100,000 Annually. 2021.
   Google Scholar
• Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and Meta-analysis of cohort studies. Addiction. 2011;106(1):32–51.
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008;17(10):997–1005.
   PubMed Web of Science ®Google Scholar
• Rigg KK, Monnat SM. Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions. Int J Drug Policy. 2015;26(5):484–491.
   PubMed Web of Science ®Google Scholar
• Amlani A, McKee G, Khamis N, et al. Why the FUSS (fentanyl urine screen study)? a cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduct J. 2015;12:54.
   PubMed Web of Science ®Google Scholar
• Bennett T, Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN project in Wales. Drugs Educ Prevent Policy. 2012;19(4):320–328.
   Web of Science ®Google Scholar
• Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in san francisco. J Urban Health. 2010;87(6):931–941.
   PubMed Web of Science ®Google Scholar
• Galea S, Worthington N, Piper TM, et al. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York city. Addict Behav. 2006;31(5):907–912.
   PubMed Web of Science ®Google Scholar
• Gaston RL, Best D, Manning V, et al. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduct J. 2009;6(1):26.
   PubMedGoogle Scholar
• Lewis DA, Park JN, Vail L, et al. Evaluation of the overdose education and naloxone distribution program of the baltimore student harm reduction coalition. Am J Public Health. 2016;106(7):1243–1246.
   PubMed Web of Science ®Google Scholar
• Piper TM, Stancliff S, Rudenstine S, et al. Evaluation of a naloxone distribution and administration program in New York city. Subst Use Misuse. 2008;43(7):858–870.
   PubMed Web of Science ®Google Scholar
• Rowe C, Santos G-M, Vittinghoff E, et al. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015;110(8):1301–1310.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the skid row area of los angeles, CA. Int J Drug Policy. 2010;21(3):186–193.
   PubMed Web of Science ®Google Scholar
• Walley AY, Doe-Simkins M, Quinn E, et al. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44(2):241–247.
   PubMed Web of Science ®Google Scholar
• McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the bradford hill criteria. Addiction. 2016;111(7):1177–1187.
   PubMed Web of Science ®Google Scholar
• Jones JD, Campbell A, Metz VE, et al. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone. Addict Behav. 2017;71:104–106.
   PubMed Web of Science ®Google Scholar
• Tse WC, Djordjevic F, Borja V, et al. Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard’ associated with naloxone supply. Int J Drug Policy. 2022;100:103513.
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Monds LA, Bravo M, et al. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: an evaluation of client outcomes and perspectives. Drug Alcohol Rev. 2020;39(1):55–65.
   PubMed Web of Science ®Google Scholar
• Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005;82(2):303–311.
   PubMed Web of Science ®Google Scholar
• Obadia Y, Feroni I, Perrin V, et al. Syringe vending machines for injection drug users: an experiment in marseille, France. Am J Public Health. 1999;89(12):1852–1854.
   PubMed Web of Science ®Google Scholar
• Islam M, Wodak A, Conigrave KM. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. Int J Drug Policy. 2008;19(6):436–441.
   PubMed Web of Science ®Google Scholar
• McDonald D. The evaluation of a trial of syringe vending machines in Canberra, Australia. Int J Drug Policy. 2009;20(4):336–339.
   PubMed Web of Science ®Google Scholar
• Cama E, Brener L, Bryant J. Characteristics and attendance patterns of a fixed-site NSP and nearby SVM: the benefits of 24-hour access to sterile injecting equipment. Drugs Educ Prevent Policy. 2014;21(6):476–481.
   Web of Science ®Google Scholar
• Islam MM, Conigrave KM. Syringe vending machines as a form of needle syringe programme: Advantages and disadvantages. J Subst Use. 2007;12(3):203–212.
   Google Scholar
• Potera C. An innovative syringe exchange program. Am J Nurs. 2017;117(7):17.
   Google Scholar
• Vegas H. Impact exchange vending machines. 2021.
   Google Scholar
• Breitenbach S. Las Vegas offers needle exchange program through vending machines. The Washington post. 2017.
   Google Scholar
• Bureau USC. QuickFacts Clark County, Nevada 2021. https://www.census.gov/quickfacts/clarkcountynevada.
   Google Scholar
• US Census Bureau. Census urban and rural classification and urban area criteria. 2010.
   Google Scholar
• District SNH. Fentanyl deaths increasing in Clark County. 2020. https://www.southernnevadahealthdistrict.org/news-release/fentanyl-deaths-increasing-in-clark-county/
   Google Scholar
• Rudd RA, Seth P, David F, et al. Increases in drug and Opioid-Involved overdose Deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(50-51):1445–1452.
   PubMed Web of Science ®Google Scholar
• Samhsa’s Center For The Application Of Prevention Technologies. Using International Classification of Diseases (ICD) codes to assess opioid-related overdose deaths. 2018.
   Google Scholar
• Schaffer AL, Dobbins TA, Pearson S-A. Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions. BMC Med Res Methodol. 2021;21(1):58.
   PubMed Web of Science ®Google Scholar
• Biglan A, Ary D, Wagenaar AC. The value of interrupted time-series experiments for community intervention research. Prev Sci. 2000;1(1):31–49.
   PubMedGoogle Scholar
• McCleary R, Hay RA, Meidinger EE, et al. Applied time series analysis for the social sciences. Beverly Hills (CA): Sage Publications; 1980.
   Google Scholar
• Li L, Cuerden MS, Liu B, et al. Three statistical approaches for assessment of intervention effects: a primer for practitioners. Risk Manag Healthc Policy. 2021;14:757–770.
   PubMed Web of Science ®Google Scholar
• Box GE, Jenkins GM. Time series analysis forecasting and control. San Francisco, CA: Wisconsin Univ Madison Dept of Statistics; 1970.
   Google Scholar
• Pridemore WA, Snowden AJ. Reduction in suicide mortality following a new national alcohol policy in Slovenia: an interrupted time-series analysis. Am J Public Health. 2009;99(5):915–920.
   PubMed Web of Science ®Google Scholar
• Ruiz MS, O'Rourke A, Allen ST. Impact evaluation of a policy intervention for HIV prevention in Washington, DC. AIDS Behav. 2016;20(1):22–28.
   PubMed Web of Science ®Google Scholar
• Ruiz MS, OʼRourke A, Allen ST, et al. Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia. J Acquir Immune Defic Syndr. 2019;82 Suppl 2(2):S148–s154.
   PubMedGoogle Scholar
• Macmadu A, Batthala S, Correia Gabel AM, et al. Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island. JAMA Netw Open. 2021;4(9):e2125538.
   PubMed Web of Science ®Google Scholar
• Saloner B, Krawczyk N, Solomon K, et al. Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey. Int J Drug Policy. 2022;101:103537.
   PubMed Web of Science ®Google Scholar
• ASAM. Public policy statement on the use of naloxone for the prevention of opioid overdose deaths; 2016.
   Google Scholar
• Irvine MA, Kuo M, Buxton JA, et al. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction. 2019;114(9):1602–1613.
   PubMed Web of Science ®Google Scholar
• Ballreich J, Mansour O, Hu E, et al. Modeling mitigation strategies to reduce Opioid-Related morbidity and mortality in the US. JAMA Netw Open. 2020;3(11):e2023677.
   PubMed Web of Science ®Google Scholar
• Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4:14.
   PubMedGoogle Scholar